15 research outputs found
Kontrola arteritisa konja na jednoj ergeli.
An epidemiology of infection with equine arteritis virus (EAV) on one stud farm with approximately 350 horses in the period from 1995 to 2008 was studied. Infection was detected by virological methods, using a virus neutralisation test (VNT) for EAV antibody detection in serum samples, and virus isolation and RT-PCR test for virus detection in semen. No clinical picture of the disease was observed. The highest seroprevalence (nearly 100%) was among stallions and old mares, while seroprevalence among young fi llies, before mating, was lower than 9%. A high incidence for seroconversion was detected among fi llies after mating. Virus was detected by RT-PCR and by a virus isolation test in the semen of 40.7% of 76 seropositive stallions. The 8 stallions, which were shedding EAV, were infected within the period of the first three years after birth, but the other 12 seropositive stallions, which were negative for EAV in semen samples, became firstly seropositive 5 years after birth. In this study we confirmed that the major transmission of EAV on the stud farm occurred from shedding stallions to fillies during the mating time, but an important role of virus transmission to other horses is also played by contact between different groups of animals. Virus positive stallions were castrated and a new breeding unit for young foals was established. EAV negative foals were vaccinated and were bred outside the farm up to 3 years of age.Prikazana je epizootiologija arteritisa konja na jednoj ergeli s 350 konja u razdoblju od 1995. do 2008. godine. Zaraza je bila dokazana na osnovi seroloÅ”ke pretrage virus neutralizacijskim testom (VNT), izdvajanja i identifikacije virusa te RT-PCR-om u sjemenu pastuha. KliniÄki znakovi bolesti nisu bili primijeÄeni. NajveÄa seroprevalencija (gotovo 100%) bila je dokazana u pastuha i starih kobila dok je seroprevalencija u ždrjebica prije pripusta bila manja od 9%. Visoka incidencija serokonverzije bila je dokazana u ždrjebica nakon pripusta. Virus je bio dokazan RT-PCR-om i izdvojen iz sjemena 40,7% od 76 seroloÅ”ki pozitivnih pastuha. Osam pastuha koji su izluÄivali virus arteritisa bilo je zaraženo u prvim trima godinama života, a ostalih 12 seroloÅ”ki pozitivnih u kojih virus nije bio izdvojen iz sjemena postali su prvi put seroloÅ”ki pozitivni pet godina nakon ždrijebljenja. PotvrÄeno je da se virus u najveÄoj mjeri prenosio s pastuha koji su izluÄivali virus na ždrjebice za vrijeme pripusta. Za prijenos virusa važan je bio i izravan dodir meÄu razliÄitim skupinama životinja. Pastusi pozitivni na virus bili su kastrirani te je osnovana nova uzgojna jedinica za ždrebad. Ždrebad negativna na virus arteritisa bila je cijepljena, a do treÄe godine držana izvan ergele
Recommendations of the Working group of the Croatian Society for Diabetes and Metabolic Disorders of the Croatian Medical Association for people with diabetes and healthcare professionals in the Republic of Croatia during COVID-19 pandemic
Radna skupina Hrvatskog druÅ”tva za dijabetes i bolesti metabolizma Hrvatskoga lijeÄniÄkog zbora pripremila je smjernice za postupanje u pandemiji COVID-19 za osobe sa Å”eÄernom boleÅ”Äu i za zdravstvene
djelatnike. U preporukama su naglaÅ”eni razmjeri pandemije i moguÄe posljedice za oboljele od Å”eÄerne bolesti. Opisana je kliniÄka slika i ponovljene smjernice Nacionalnog stožera civilne zaÅ”tite kako se osobe od Å”eÄerne bolesti mogu zaÅ”tititi i Å”to trebaju Äiniti za dobru regulaciju glikemije. Predložene su mjere koje trebaju provoditi zdravstvene
ustanove koje skrbe o bolesnicima sa Å”eÄernom boleÅ”Äu i naÄela zbrinjavanja glikemije u hitnom prijemu i tijekom hospitalizacije.The Working group of the Croatian Society for Diabetes and Metabolic Disorders of the Croatian Medical Association has prepared recommendations for people with diabetes and healthcare professionals in the age of COVID-19 pandemic. The recommendations emphasized the scale of the pandemic and the possible consequences
for those suffering from diabetes. Enclosed are clinical presentation and directions of the National civil protection headquarters on the methods that enable people with diabetes to protect themselves, and maintain
their blood glucose in target range as well. Measures have been proposed to be implemented by healthcare facilities that deliver care for patients with diabetes, and the principles of glycemic control in emergency department and during hospitalization
Hrvatske smjernice za farmakoloÅ”ko lijeÄenje Å”eÄerne bolesti tipa 2 [Croatian guidelines for the pharmacotherapy of type 2 diabetes]
Introduction: The Croatian Association for Diabetes and Metabolic Disorders of the Croatian Medical Association has issued in 2011 the first national guidelines for the nutrition, education, self-control, and pharmacotherapy of diabetes type 2. According to the increased number of available medicines and new evidence related to the effectiveness and safety of medicines already involved in the therapy there was a need for update of the existing guidelines for the pharmacotherapy of type 2 diabetes in the Republic of Croatia.
Participants: as co-authors of the Guidelines there are listed all members of the Croatian Association for Diabetes and Metabolic Diseases, as well as other representatives of professional societies within the Croatian Medical Association, who have contributed with comments and suggestions to the development of the Guidelines. Evidence: These guidelines are evidence-based, according to the GRADE system (eng. Grading of Recommendations, Assessment, Development and Evaluation), which describes the level of evidence and strength of recommendations. Conclusions: An individual patient approach based on physiological principles in blood glucose control is essential for diabetes' patients management. Glycemic targets and selection of the pharmacological agents should be tailored to the patient, taking into account the age, duration of disease, life expectancy, risk of hypoglyce- mia, comorbidities, developed vascular and other complications as well as other factors. Because of all this, is of national interest to have a practical, rational and applicable guidelines for the pharmacotherapy of type 2 diabetes
CROATIAN GUIDELINES FOR THE PHARMACOTHERAPY OF TYPE 2 DIABETES
Uvod: Hrvatsko druÅ”tvo za dijabetes i bolesti metabolizma Hrvatskoga lijeÄniÄkog zbora izradilo je 2011. godine prve nacionalne smjernice o prehrani, edukaciji i samokontroli te farmakoloÅ”kom lijeÄenju Å”eÄerne bolesti tipa 2. Sukladno poveÄanom broju dostupnih lijekova te novim spoznajama o uÄinkovitosti i sigurnosti primjene veÄ ukljuÄenih lijekova, pokazala se potreba za obnovom postojeÄih smjernica za farmakoloÅ”ko lijeÄenje Å”eÄerne bolesti tipa 2 u Republici ĀHrvatskoj. Sudionici: Kao koautori Smjernica navedeni su svi Älanovi Hrvatskog druÅ”tva za dijabetes i bolesti metabolizma Hrvatskoga lijeÄniÄkog zbora, kao i ostalih ukljuÄenih struÄnih druÅ”tava, koji su svojim komentarima i prijedlozima pridonijeli izradi Smjernica. Dokazi: Ove su Smjernice utemeljene na dokazima, prema sustavu GRADE (engl. Grading of Recommendations, Assessment, Development and Evaluation) koji uz razinu dokaza opisuje i snagu preporuke. ZakljuÄci: Individualan pristup temeljen na fizioloÅ”kim principima regulacije glikemije nuždan je u lijeÄenju osoba sa Å”eÄernom bolesti. Ciljeve lijeÄenja i odabir medikamentne terapije treba prilagoditi oboljeloj osobi, uzimajuÄi u obzir životnu dob, trajanje bolesti, oÄekivano trajanje života, rizik od hipoglikemije, komorbiditete, razvijene vaskularne i ostale komplikacije, kao i ostale Äimbenike. Zbog svega navedenoga od nacionalnog je interesa imati praktiÄne, racionalne i provedive smjernice za farmakoloÅ”ko lijeÄenje Å”eÄerne bolesti tipa 2.Introduction: The Croatian Association for Diabetes and Metabolic Disorders of the Croatian Medical Association has issued in 2011 the first national guidelines for the nutrition, education, self-control, and pharmacotherapy of Ādiabetes type 2. According to the increased number of available medicines and new evidence related to the effectiveness and safety of medicines already involved in the therapy there was a need for update of the existing guidelines for the Āpharmacotherapy of type 2 diabetes in the Republic of Croatia. Participants: as co-authors of the Guidelines there are listed all members of the Croatian Association for Diabetes and Metabolic Diseases, as well as other representatives of professional societies within the Croatian Medical Association, who have contributed with comments and suggestions to the development of the Guidelines. Evidence: These guidelines are evidence-based, according to the GRADE system (eng. Grading of Recommendations, Assessment, Development and Evaluation), which describes the level of evidence and strength of recommendations. Conclusions: An individual patient approach based on physiological principles in blood glucose control is essential for diabetesā patients management. Glycemic targets and selection of the pharmacological agents should be tailored to the patient, taking into account the age, duration of disease, life expectancy, risk of hypoglycemia, comorbidities, developed vascular and other complications as well as other factors. Because of all this, is of national interest to have a practical, rational and applicable guidelines for the pharmacotherapy of type 2 diabetes
Equine viral arteritis
Equine viral arteritis (EVA) is a contagious disease of equids caused by
equine artheritis virus (EAV), widespread in most countries in the world,
where patients are diagnosed. The infection usually starts asymptomatic.
Clinical signs indicate respiratory infection of different intensity and
also abortions are present at different stages of gestation. Large
prevalence of this disease in the world has become a growing economic
problem. The disease is specific to a particular kind of animals, and it
affects only equids (horses, donkeys, mules, mule and zebras). In countries
where the infection has been confirmed, the percentage of positive animals
differ. Likewise, there is difference in percentage among certain animal
kinds. The highest percentage of positive animals has been found in totters
and the lowest in cold-blooded
Influence of sexually transmitted infections in a horse breeding
The most frequent problems in horses reproduction are generally divided into
those of infectious and non infectious etiology. Common causes of infectious
diseases are usualĀly viruses and bacteria, and less frequently protozoa,
mykoplasma and fungi. In this work there are presented the most important
fact about sexually transmitted diseases, their clinical picture, risk
factors, preventive measures as well as measures to prevent and eradicate the
diseases. The biggest risk factor for sexually transmitted diseases in horses
are breeding stallions, both in natural mating and in artificial
insemination. Therefore, in order to prevent genital infections in horses, it
is essential that the stallions used for breeding are healthy (non-infected).
That can be determined with certainty only if the stallions are examined
(tested) just before the breeding season on most frequent sexually
transmitted diseases (CEM,EAV). It is well known that in most cases the
clinical picture of sexually transmitted diseses is not manifested on
genitals. As well, variations in clinical picture can be expected also in
mares, depending on the stage of the disease and its etiology. Harms arising
from sexually transmitted diseases can be divided into direct and indirect.
Direct damage occurs in the form of endometritis, miscarriage, stillbirths
and births of weak foals, and indirect in restricting the traffic of infected
and suspicios animals, isolation of the infected ones as well as medical
treatment and interrupting mating
Monitoring of unhatched eggs in HermannŹ¼s tortoise (Testudo hermanni) after artificial incubation and possible improvements in hatching
The causes of embryonic mortality in Hermannās tortoises (Testudo hermanni) during artificial incubation were determined. Total egg failure at the end of the hatching period was investigated. The hatching artefacts represented 19.2% (N = 3557) of all eggs (N = 18,520). The viability rate of incubated eggs was 80.8%. The eggs, i.e., embryos, were sorted according to the cause of unsuccessful hatching and subsequently analyzed. Some of the eggs were divided into two or more groups. Unfertilized eggs were confirmed in 61.0%, infected eggs in 52.5%, and eggs in various stages of desiccation in 19.1%. This group also included mummified embryos. Pseudomonas aeruginosa, Bacillus sp., Purpureocillium lilacinum, and Escherichia coli were frequently confirmed in infected eggs. Embryos were divided into three groups: embryos up to 1.0 cmāgroup 1 (2.2%), embryos from 1.0 cm to 1.5 cmāgroup 2 (5.4%) and embryos longer than 1.5 cmāgroup 3 (7.3%) of all unhatched eggs. Inability of embryos to peck the shell was found in 1.3%. These tortoises died shortly before hatching. Embryos still alive from the group 2 and group 3 were confirmed in 0.7% of cases. Dead and alive deformed embryos and twins were detected in the group 3 in 0.5% and 0.1% of cases, respectively. For successful artificial hatching, it is important to establish fumigation with disinfectants prior to incubation and elimination of eggs with different shapes, eggs with broken shells, and eggs weighted under 10 g. Eggs should be candled before and periodically during artificial incubation, and all unfertilized and dead embryos must be removed. Heartbeat monitor is recommended. Proper temperature and humidity, incubation of ācleanā eggs on sterile substrate and control for the presence of mites is essential. Monitoring of the parent tortoises is also necessary